Cue Biopharma, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-06-30
Reported
2025-08-12
Disclosure lag
43 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityCue Biopharma, Inc.
SourceSEC EDGAR
Source identifiercompanyfacts/CIK0001645460/2026-07-26
Event ID#27576

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0000950170-25-107270",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "Q2",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.05185185185185185,
  "metrics": {
    "cash_and_equivalents": 27492000,
    "earnings_per_share_basic": -0.09,
    "earnings_per_share_diluted": -0.09,
    "net_income": -8482000,
    "operating_income": -8635000,
    "revenue": 2954000,
    "shareholders_equity": 18159000,
    "shares_outstanding": 76446884,
    "total_assets": 40707000,
    "total_liabilities": 22548000
  },
  "metrics_reported": 10,
  "period_end": "2025-06-30"
}

Source: SEC EDGAR · as of 2025-08-12T00:00:00Z

Cue Biopharma, Inc. — recorded event — Tapewire